Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05934565 · ClinicalTrials.gov registry record · NA
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
A NA study of Chronic Obstructive Pulmonary Disease and Chronic Heart Failure, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 2
- Study locations
NCT05934565: Recruiting NA study of Chronic Obstructive Pulmonary Disease and Chronic Heart Failure, sponsored by Beth Israel Deaconess Medical Center.
NCT05934565 is a NA study of Chronic Obstructive Pulmonary Disease and Chronic Heart Failure that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 136 participants, below the 1,752-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05934565, a NA study of Chronic Obstructive Pulmonary Disease and Chronic Heart Failure, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF. Participants will be randomized (1:1 ratio) to receive either the Mindful Steps intervention or usual care for 12 months, with both arms receiving a Walking for Health education booklet.
Primary Outcome
Daily step counts will be measured as an objective proxy for physical activity using FitBit pedometers (FitBit Inspire 3)
Conditions Studied
Interventions
- BEHAVIORAL Mindful Steps
Study Locations (2)
Massachusetts
- VA Boston - Boston
- BIDMC - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2025-04-28 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT05934565 shows while recruiting
NCT05934565 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,752-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which Mindful Steps is the first listed.
NCT05934565 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05934565 about?
NCT05934565 is a clinical study titled "Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF". The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as me...
What is the current status of trial NCT05934565?
This trial is currently recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2025-04-28. Estimated completion is 2028-06-30.
What conditions does trial NCT05934565 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease, Chronic Heart Failure.
What interventions are being tested in trial NCT05934565?
The interventions under investigation include: Mindful Steps (BEHAVIORAL).
Who is sponsoring clinical trial NCT05934565?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05934565 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05934565's enrollment target sits among peer trials
136 44th of 86 higher than 43 of 86 other Chronic Obstructive Pulmonary Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
RECRUITING · NA
-
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
RECRUITING · NA
-
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
RECRUITING · NA
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI